Acción SYNGENE SYNGENE INTERNATIONAL LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Syngene International Limited Bombay S.E.

Acciones

SYNGENE

INE398R01022

Mercado cerrado - Bombay S.E.
Otros sitios de cotización
 12:00:50 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
698,2 INR -0,10 % Gráfico intradía de Syngene International Limited -2,11 % -0,41 %
26/04 SYNGENE INTERNATIONAL LIMITED : Jefferies & Co. establece una nueva recomendación de venta ZM
25/04 Transcript : Syngene International Limited, Q4 2024 Earnings Call, Apr 25, 2024

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Syngene International Limited Recommends Final Dividend for the Financial Year 2024
Syngene International Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes
Syngene Biologics Manufacturing Facility to Be Operational for U.S. and European Customers from Mid-Year
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
Syngene International Posts Gains in Fiscal Q3 Consolidated Net Profit
Syngene International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Syngene International Limited Appoints Mr. Sibaji Biswas as Additional Director Designated as Executive Director, Effective on April 01, 2024
Syngene International Completes Acquisition of Stelis Biopharma's Biologics Plant
Syngene International Limited completed the acquisition of Unit 3 biologics manufacturing facility in Bangalore from Stelis Biopharma Private Limited for INR 6.2 billion.
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China
Syngene International COO Steps Down
Syngene International Limited Announces Resignation of Mahesh Bhalgat as Chief Operating Officer, Effective January 31, 2024
Syngene International Limited Announces Resignation of Carl Decicco as Non-Executive Director
Syngene International's Consolidated Profit Jumps in Fiscal Q2; Shares Slump 7%
Syngene International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Syngene International Limited Announces Retirement of Joydeep Kant as Sr. Vice President - Development Services, Effective October 31, 2023
Syngene International Limited(NSEI:SYNGENE) added to FTSE All-World Index
Syngene International Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción SYNGENE
  4. Acción SYNGENE
  5. Noticias Syngene International Limited
  6. Otros idiomas